About UR Advanced Therapeutics
UR Advanced Therapeutics is a company based in Hyderabad (India). It operates as a B2B. The company has 1 employees as of March 31, 2023. UR Advanced Therapeutics offers products and services including Dynamic Apoptosis Detection (DAD)-Kit, CytoFLASH, ViaBLUE Cell Proliferation Kit, High-Expression Bacterial Vectors, and Wet Laboratory Services. UR Advanced Therapeutics operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter Hyderabad, India
- Employees 1 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ur Advanced Therapeutics Private Limited
- Date of Incorporation 17 Jul, 2020
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$14.94 K (USD)314.23as on Mar 31, 2023
-
Net Profit
-$9.23 K (USD)37.37as on Mar 31, 2023
-
EBITDA
-$4.52 K (USD)65.12as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UR Advanced Therapeutics
UR Advanced Therapeutics offers a comprehensive portfolio of products and services, including Dynamic Apoptosis Detection (DAD)-Kit, CytoFLASH, ViaBLUE Cell Proliferation Kit, High-Expression Bacterial Vectors, and Wet Laboratory Services.
Kit for early and late apoptosis detection in cells.
Fluorescent biosensor for identifying live proliferating cells.
Assay to quantitate live cells with high signal sensitivity.
Custom promoters for over-expression of genes of interest.
Provides cell cultures and drug screening for research.
Offers data analysis and molecular docking for drug discovery.
Funding Insights of UR Advanced Therapeutics
Detailed funding history for UR Advanced Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UR Advanced Therapeutics
Investment portfolio details for UR Advanced Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - UR Advanced Therapeutics
Detailed financials for UR Advanced Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ur Advanced Therapeutics Comparisons
Peer comparison for UR Advanced Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UR Advanced Therapeutics
UR Advanced Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
Detailed competitors of UR Advanced Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ur Advanced Therapeutics
Complete news archive for UR Advanced Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UR Advanced Therapeutics
UR Advanced Therapeutics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at UR Advanced Therapeutics is 1.
Annual revenue of UR Advanced Therapeutics is $14.94K as on Mar 31, 2023.
UR Advanced Therapeutics engineers personalized medicine using biomaterials and stem cell technologies. They design de novo peptides for applications in tissue engineering, therapeutics, and drug discovery. Based in Hyderabad, India, they offer products like detection kits and services including cell cultures, flow cytometry, and in-silico analysis. Their focus is on advancing scientific research without promoting specific outcomes.
UR Advanced Therapeutics's top competitors include CytoTronics, Kiyatec and Remedy Plan.
UR Advanced Therapeutics offers Dynamic Apoptosis Detection (DAD)-Kit, CytoFLASH, ViaBLUE Cell Proliferation Kit, High-Expression Bacterial Vectors, and 2 more products and services.